Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Many funds are self-restricted not to invest in ACE-market stocks whose risks are seen as higher. After transferring to Main Board, Bioalpha is able to lure more institutional investors.
